221 related articles for article (PubMed ID: 9313205)
21. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
22. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
24. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3.
Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G;
Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648
[TBL] [Abstract][Full Text] [Related]
25. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
Doan S; Badelon I; Chaine G
J Fr Ophtalmol; 1998 Jan; 21(1):34-41. PubMed ID: 9834898
[TBL] [Abstract][Full Text] [Related]
26. In vitro cytopathogenicity of the human immunodeficiency virus (HIV)-1 predicts survival in HIV-infected hemophiliacs independent from CD4 cell count.
Rockstroh JK; Woitas RP; Brackmann HH; Kupfer B; Kaiser R; Schneweis KE; Sudhop T; Spengler U
Eur J Med Res; 1998 May; 3(5):223-30. PubMed ID: 9580568
[TBL] [Abstract][Full Text] [Related]
27. [Risk of the development of dementia after interruption of zidovudine treatment].
Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM
Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533
[TBL] [Abstract][Full Text] [Related]
28. Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.
Erbelding EJ; Chaisson RE; Gallant JE; Moore RD
Antivir Ther; 1997 Apr; 2(2):71-7. PubMed ID: 11322278
[TBL] [Abstract][Full Text] [Related]
29. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
[TBL] [Abstract][Full Text] [Related]
30. Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis.
Martin BK; Ricks MO; Forman MS; Jabs DA;
Clin Infect Dis; 2007 Apr; 44(7):1001-8. PubMed ID: 17342657
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
Sungkanuparph S; Chakriyanuyok T; Butthum B
J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
33. [AIDS in Denmark. 2. Survival after the diagnosis of AIDS. Danish Study Group for HIV infection].
Lundgren JD; Pedersen C; Bentsen KD; Gerstoft J; Seefeldt-Nielsen T; Nielsen TL; Jensen GF
Ugeskr Laeger; 1995 Mar; 157(10):1352-6. PubMed ID: 7709483
[TBL] [Abstract][Full Text] [Related]
34. Factors affecting survival in patients with the acquired immunodeficiency syndrome.
Mocroft A; Johnson MA; Phillips AN
AIDS; 1996 Sep; 10(10):1057-65. PubMed ID: 8874621
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of AIDS patients with zidovudine].
Buijs L; Pietersz RN; van den Berg-Wolf MG; Reesink HW; ten Veen JH
Ned Tijdschr Geneeskd; 1990 Jan; 134(2):71-5. PubMed ID: 2296325
[TBL] [Abstract][Full Text] [Related]
36. A pooled analysis of CD4 response to zidovudine and zalcitabine treatment in patients with AIDS and AIDS-related complex.
Gries JM; Troconiz IF; Verotta D; Jacobson M; Sheiner LB
Clin Pharmacol Ther; 1997 Jan; 61(1):70-82. PubMed ID: 9024175
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group.
Burke M; Yust I; Katlama C; Vardinon N; Clumeck N; Pinching AJ; Ledergerber B; Gatell JM; Chiesi A; Barton SE; Lundgren JD; Pedersen C
Eur J Clin Microbiol Infect Dis; 1997 Dec; 16(12):876-82. PubMed ID: 9495667
[TBL] [Abstract][Full Text] [Related]
38. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
Cox PH; Martin MA; Styer CM; Beall GN
Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
[TBL] [Abstract][Full Text] [Related]
40. Zidovudine and the natural history of the acquired immunodeficiency syndrome.
Moore RD; Hidalgo J; Sugland BW; Chaisson RE
N Engl J Med; 1991 May; 324(20):1412-6. PubMed ID: 2020297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]